These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3348245)

  • 1. Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis.
    Recht L; Straus DJ; Cirrincione C; Thaler HT; Posner JB
    Am J Med; 1988 Mar; 84(3 Pt 1):425-35. PubMed ID: 3348245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary involvement of the central nervous system in malignant non-Hodgkin's lymphoma. A study of 30 cases in a series of 498 patients.
    Hoerni-Simon G; Suchaud JP; Eghbali H; Coindre JM; Hoerni B
    Oncology; 1987; 44(2):98-101. PubMed ID: 3574856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system involvement in non-Hodgkin's lymphomas: value of lumbar puncture as initial staging procedure.
    Monfardini S; Ficarra G; Giardini R; Santoro A
    Tumori; 1981; 67(3):197-202. PubMed ID: 7281238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system involvement in non-Hodgkin's lymphoma.
    Liang RH; Woo EK; Yu YL; Todd D; Chan TK; Ho FC; Tso SC; Shum JS
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):703-10. PubMed ID: 2714346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
    Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H
    Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediate-grade non-Hodgkin's lymphoma.
    Chua SL; Seymour JF; Streater J; Wolf MM; Januszewicz EH; Prince HM
    Leuk Lymphoma; 2002 Sep; 43(9):1783-8. PubMed ID: 12685832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Hodgkin's lymphoma of the central nervous system after treatment of Hodgkin's disease.
    Miller DC; Knee R; Schoenfeld S; Wasserstrom WR; Karp G
    Am J Clin Pathol; 1989 Apr; 91(4):481-5. PubMed ID: 2929506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system relapse of systemic non-Hodgkin's lymphoma: results of treatment based on high-dose methotrexate combination chemotherapy.
    Bokstein F; Lossos A; Lossos IS; Siegal T
    Leuk Lymphoma; 2002 Mar; 43(3):587-93. PubMed ID: 12002763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for central nervous system involvement in non-Hodgkin's lymphoma: significance of very high serum LDH concentrations.
    Tomita N; Kodama F; Sakai R; Koharasawa H; Hattori M; Taguchi J; Fujita H; Tanabe J; Fujisawa S; Fukawa H; Harano H; Kanamori H; Miyashita H; Matsuzaki M; Ogawa K; Motomura S; Maruta A; Ishigatsubo Y
    Leuk Lymphoma; 2000 Jul; 38(3-4):335-43. PubMed ID: 10830740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNS involvement by non-Hodgkin's lymphoma. Response to a standard therapeutic protocol.
    Raz I; Siegal T; Siegal T; Polliack A
    Arch Neurol; 1984 Nov; 41(11):1167-71. PubMed ID: 6487100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system involvement in T-cell lymphoma: A single center experience.
    Gurion R; Mehta N; Migliacci JC; Zelenetz A; Moskowitz A; Lunning M; Moskowitz C; Hamlin P; Horwitz S
    Acta Oncol; 2016 May; 55(5):561-6. PubMed ID: 27046135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNS involvement in the non-Hodgkin's lymphomas.
    Levitt LJ; Dawson DM; Rosenthal DS; Moloney WC
    Cancer; 1980 Feb; 45(3):545-52. PubMed ID: 6986199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nervous system complications by malignant lymphomas: radiation schedule and treatment results.
    Aabo K; Walbom-Jørgensen S
    Int J Radiat Oncol Biol Phys; 1986 Feb; 12(2):197-202. PubMed ID: 3949570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
    Carella AM; Cavaliere M; Lerma E; Ferrara R; Tedeschi L; Romanelli A; Vinci M; Pinotti G; Lambelet P; Loni C; Verdiani S; De Stefano F; Valbonesi M; Corsetti MT
    J Clin Oncol; 2000 Dec; 18(23):3918-24. PubMed ID: 11099321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society.
    Patte C; Philip T; Rodary C; Bernard A; Zucker JM; Bernard JL; Robert A; Rialland X; Benz-Lemoine E; Demeocq F
    J Clin Oncol; 1986 Aug; 4(8):1219-26. PubMed ID: 3525767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failed central nervous system prophylaxis in children with acute lymphoblastic leukaemia: treatment and outcome.
    Pinkerton CR; Chessells JM
    Br J Haematol; 1984 Aug; 57(4):553-61. PubMed ID: 6589013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Outcomes of Diffuse Large B-cell Lymphoma Patients with Synchronous and Early Central Nervous System Involvement: A Single-Center Experience.
    Al-Mansour M; Saif SA; Alharbi Z; Alhwaity AS; Almasrahi A; Alnejadi W; Hussain S; Aga SS; Khan MA; Almufti R; Absi A
    Asian Pac J Cancer Prev; 2023 Feb; 24(2):623-631. PubMed ID: 36853313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?
    O'Neill BP; O'Fallon JR; Earle JD; Colgan JP; Brown LD; Krigel RL
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):663-73. PubMed ID: 7558957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.